Study: Experimental drug shrinks cancer tumors

<p>An initial cancer drug successfully shrank tumors in patients with opposite kinds of cancer, including typically hard-to-treat lung cancers, according to a new study. Oncologists pronounced a investigate was encouraging, though some-more investigate was indispensable to know either a drug would lengthen life for cancer patients.</p>

<p>
The study, led by Dr. Suzanne Topalian, was presented Friday during a Super Bowl of cancer professionals, a assembly of a American Society of Clinical Oncology, and published in a New England Journal of Medicine.</p>

<p>
In a small, early proviso study, researchers used a drug targeting a apportionment of a bodys defence system, a pathway called PD-1, that customarily works to stop a physique from fighting carcenogenic tumors. By shutting down a pathway, a drug stokes a bodys defence complement to quarrel growth cells.</p>

<p>
Researchers gave a drug to scarcely 240 patients with modernized melanoma, color...